Marc-emile Plourde

Sherbrooke, QC J1G2E8, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

In patients with cardiovascular disease, is targeting an LDL below 1.4mmol/L more effective than targeting an LDL below 1.8mmol/L in preventing major cardiovascular events?

In patients with cardiovascular disease, is targeting an LDL below 1.4mmol/L more effective than targeting an LDL below 1.8mmol/L in preventing major cardiovascular events?

Journal: La Revue de medecine interne

Published: May 25, 2026

In patients with acute symptomatic venous thromboembolism, does apixaban reduce the risk of clinically relevant bleeding at 3 months compared to rivaroxaban, while being equally effective?

In patients with acute symptomatic venous thromboembolism, does apixaban reduce the risk of clinically relevant bleeding at 3 months compared to rivaroxaban, while being equally effective?

Journal: La Revue de medecine interne

Published: May 06, 2026

In patients presenting to the emergency department with suspected leg deep vein thrombosis, would the use of an age-adjusted D-dimer threshold reduce the use of ultrasound without compromising safety?

In patients presenting to the emergency department with suspected leg deep vein thrombosis, would the use of an age-adjusted D-dimer threshold reduce the use of ultrasound without compromising safety?

Journal: La Revue de medecine interne

Published: March 20, 2026

In patients with severe asymptomatic carotid stenosis, is carotid stenting or carotid endarterectomy combined with intensive medical treatment more effective than intensive medical treatment alone in preventing stroke?

In patients with severe asymptomatic carotid stenosis, is carotid stenting or carotid endarterectomy combined with intensive medical treatment more effective than intensive medical treatment alone in preventing stroke?

Journal: La Revue de medecine interne

Published: January 30, 2026

In patients at high cardiovascular risk, with atherosclerosis or diabetes, but without a history of myocardial infarction or stroke, does treatment with evolocumab reduce major cardiovascular events compared to placebo, while being safe?

In patients at high cardiovascular risk, with atherosclerosis or diabetes, but without a history of myocardial infarction or stroke, does treatment with evolocumab reduce major cardiovascular events compared to placebo, while being safe?

Journal: La Revue de medecine interne

Published: December 19, 2025

In patients with ischemic stroke, with symptom onset between 4.5 and 24hours, and salvageable brain parenchyma assessed by perfusion CT, without a plan for thrombectomy, does alteplase improve functional independence at 90 days, compared with standard therapy, while being safe?

In patients with ischemic stroke, with symptom onset between 4.5 and 24hours, and salvageable brain parenchyma assessed by perfusion CT, without a plan for thrombectomy, does alteplase improve functional independence at 90 days, compared with standard therapy, while being safe?

Journal: La Revue de medecine interne

Published: October 31, 2025

In patients with metabolic dysfunction-associated steatohepatitis and moderate to advanced liver fibrosis, does semaglutide (2.4mg subcutaneously every week) improve liver histology compared to placebo, and is it safe?

In patients with metabolic dysfunction-associated steatohepatitis and moderate to advanced liver fibrosis, does semaglutide (2.4mg subcutaneously every week) improve liver histology compared to placebo, and is it safe?

Journal: La Revue de medecine interne

Published: August 22, 2025

In patients with active cancer and venous thromboembolism who have been anticoagulated for at least 6 months, is extended treatment with a reduced dose of apixaban effective in preventing recurrences and reducing the risk of bleeding, compared to a full dose?

In patients with active cancer and venous thromboembolism who have been anticoagulated for at least 6 months, is extended treatment with a reduced dose of apixaban effective in preventing recurrences and reducing the risk of bleeding, compared to a full dose?

Journal: La Revue de medecine interne

Published: June 02, 2025

In patients with type 2 diabetes at high risk of cardiovascular events, does oral semaglutide decrease the risk of major adverse cardiovascular events compared to placebo, and is it safe?

In patients with type 2 diabetes at high risk of cardiovascular events, does oral semaglutide decrease the risk of major adverse cardiovascular events compared to placebo, and is it safe?

Journal: La Revue de medecine interne

Published: May 02, 2025

In patients with asymptomatic severe aortic stenosis, does a transcatheter aortic-valve replacement improve prognosis, and is it safe?

In patients with asymptomatic severe aortic stenosis, does a transcatheter aortic-valve replacement improve prognosis, and is it safe?

Journal: La Revue de medecine interne

Published: March 26, 2025

In hospitalized patients with bacteremia, is a 7-day antibiotic treatment noninferior to a 14-day treatment with respect to mortality?

In hospitalized patients with bacteremia, is a 7-day antibiotic treatment noninferior to a 14-day treatment with respect to mortality?

Journal: La Revue de medecine interne

Published: January 29, 2025

In patients with obesity and moderate to severe obstructive sleep apnea, is tirzepatide effective in reducing the apnea-hypopnea index compared to placebo, and is it safe?

In patients with obesity and moderate to severe obstructive sleep apnea, is tirzepatide effective in reducing the apnea-hypopnea index compared to placebo, and is it safe?

Journal: La Revue de medecine interne

Published: December 06, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026